Table 4 Joinpoint analysis of cancer mortality by the main sites for age-standardized rates for both sexes. Sergipe, 1980–2018.

From: Temporal trend of cancer mortality in a Brazilian state with a medium Human Development Index (1980–2018)

Sites

JP

APC

95% CI

AAPC

95% CI

Male

Prostate

1

(1980–2010) 6.82a

5.40; 8.25

5.32a

3.87; 6.80

(2010–2018) − 0.09

− 4.66; 4.69

  

Lung/trachea/bronchus

2

(1980–1998) 1.55

− 0.42; 3.57

1.72a

0.11; 3.35

(1998–2005) 8.47a

1.37; 16.08

  

(2005–2018) − 1.53

− 3.16; 0.13

  

Stomach

2

(1980–2001) − 1.08

− 2.89; 0.76

0.74

− 2.25; 3.83

(2001–2005) 19.07

− 9.37; 56.42

  

(2005–2018) − 1.43

− 3.57; 0.75

  

Oral cavity

4

(1980–1988) − 14.85a

− 26.35; − 1.55

1.79

− 5.17; 9.25

(1988–1993) 36.90

− 4.90; 97.07

  

(1993–1999) − 14.29

− 31.03; 6.52

  

(1999–2004) 30.90a

2.20; 67.66

  

(2004–2018) − 0.24

− 2.33; 1,90

  

Liver/IHBD

0

(1980–2018) 2.26a

1.46; 3.07

2.26a

1.46; 3.07

Female

Breast

0

(1980–2018) 3.55a

3.01; 4.09

3.55a

3.01; 4.09

Lung/trachea/bronchus

0

(1980–2018) 2.80a

2.14; 3.48

2.80a

2.14; 3.48

Cervix

0

(1980–2018) − 0.01

− 0.76; 0.74

− 0.01

− 0.76; 0.74

Colon/rectum

1

(1980–2015) 4.02a

3.08; 4.98

4.85a

3.25; 6.48

(2015–2018) 15.00

− 3.22; 36.65

  

CNS

1

(1980–2006) 7.31a

5.02; 9.65

5.04a

3.31; 6.80

(2006–2018) 0.28

− 2.51; 3.14

  
  1. JP number of join points, APC annual percent change, AAPC average annual percent change, CI Confidence interval, CNS central nervous system, IHBD intrahepatic bile ducts.
  2. aAPC/AAPC statistically significant.